Armando Zúñiga

706 total citations
15 papers, 573 citations indexed

About

Armando Zúñiga is a scholar working on Epidemiology, Infectious Diseases and Genetics. According to data from OpenAlex, Armando Zúñiga has authored 15 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 5 papers in Infectious Diseases and 3 papers in Genetics. Recurrent topics in Armando Zúñiga's work include Respiratory viral infections research (9 papers), Virology and Viral Diseases (8 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Armando Zúñiga is often cited by papers focused on Respiratory viral infections research (9 papers), Virology and Viral Diseases (8 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Armando Zúñiga collaborates with scholars based in Switzerland, United States and France. Armando Zúñiga's co-authors include Hussein Y. Naim, Matthias Liniger, Martin Billeter, René R. Marty, Jovan Pavlovic, Marlyse C. Knuchel, Lars Hangartner, Reinhard Glueck, Marian Wiegand and Reto A. Schwendener and has published in prestigious journals such as Journal of Virology, Vaccine and Immunology and Cell Biology.

In The Last Decade

Armando Zúñiga

14 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Armando Zúñiga Switzerland	12	343	251	127	118	87	15	573
Inge Thoelen Belgium	11	175 0.5×	529 2.1×	134 1.1×	78 0.7×	120 1.4×	17	826
Selma A. Gomes Brazil	25	1.3k 3.7×	488 1.9×	174 1.4×	76 0.6×	78 0.9×	66	1.7k
Feliciano Milián-Suazo Mexico	14	275 0.8×	307 1.2×	81 0.6×	31 0.3×	37 0.4×	32	524
Len Dally United States	14	164 0.5×	365 1.5×	72 0.6×	148 1.3×	113 1.3×	20	685
Ila Singh United States	12	168 0.5×	156 0.6×	139 1.1×	92 0.8×	157 1.8×	32	575
Angela Carville United States	17	303 0.9×	313 1.2×	71 0.6×	194 1.6×	75 0.9×	28	681
Andrew D. Murdin United States	16	288 0.8×	189 0.8×	52 0.4×	288 2.4×	152 1.7×	27	861
Labib Bakkali‐Kassimi France	13	114 0.3×	346 1.4×	50 0.4×	73 0.6×	114 1.3×	35	781
Ariane Rodrı́guez Netherlands	13	223 0.7×	325 1.3×	85 0.7×	294 2.5×	136 1.6×	17	605
R. Joyce Verburgh Netherlands	14	562 1.6×	261 1.0×	88 0.7×	209 1.8×	62 0.7×	18	690

Countries citing papers authored by Armando Zúñiga

Since Specialization

Citations

This map shows the geographic impact of Armando Zúñiga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armando Zúñiga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armando Zúñiga more than expected).

Fields of papers citing papers by Armando Zúñiga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Armando Zúñiga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armando Zúñiga. The network helps show where Armando Zúñiga may publish in the future.

Co-authorship network of co-authors of Armando Zúñiga

This figure shows the co-authorship network connecting the top 25 collaborators of Armando Zúñiga. A scholar is included among the top collaborators of Armando Zúñiga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Armando Zúñiga. Armando Zúñiga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Zúñiga, Armando, et al.. (2021). An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus. npj Vaccines. 6(1). 85–85. 12 indexed citations

Hervé, Pierre‐Louis, Véronique Dhelft, Armando Zúñiga, et al.. (2021). Epicutaneous immunization using synthetic virus-like particles efficiently boosts protective immunity to respiratory syncytial virus. Vaccine. 39(32). 4555–4563. 8 indexed citations

Zúñiga, Armando, et al.. (2021). Author Correction: An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus. npj Vaccines. 6(1). 111–111.

Tamborrini, Marco, Julia Hauser, Araceli Lamelas, et al.. (2015). A Synthetic Virus-Like Particle Streptococcal Vaccine Candidate Using B-Cell Epitopes from the Proline-Rich Region of Pneumococcal Surface Protein A. Vaccines. 3(4). 850–874. 24 indexed citations

Knuchel, Marlyse C., et al.. (2013). Relevance of a pre-existing measles immunity prior immunization with a recombinant measles virus vector. Human Vaccines & Immunotherapeutics. 9(3). 599–606. 29 indexed citations

Cantarella, Giuseppina, Matthias Liniger, Armando Zúñiga, et al.. (2009). Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma. Vaccine. 27(25-26). 3385–3390. 39 indexed citations

Liniger, Matthias, Armando Zúñiga, René R. Marty, et al.. (2009). Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses. Vaccine. 27(25-26). 3299–3305. 40 indexed citations

Liniger, Matthias, Armando Zúñiga, Azaibi Tamin, et al.. (2008). Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses. Vaccine. 26(17). 2164–2174. 68 indexed citations

Zúñiga, Armando, Zili Wang, Matthias Liniger, et al.. (2007). Attenuated measles virus as a vaccine vector. Vaccine. 25(16). 2974–2983. 70 indexed citations

10.

Liniger, Matthias, Armando Zúñiga, & Hussein Y. Naim. (2007). Use of viral vectors for the development of vaccines. Expert Review of Vaccines. 6(2). 255–266. 101 indexed citations

11.

Zúñiga, Armando, et al.. (2004). The use of a multidisciplinary team care approach to improve glycemic control and quality of life by the prevention of complications among diabetic patients.. PubMed. 97(5). 201–4. 33 indexed citations

12.

Hangartner, Lars, et al.. (2001). Recombinant measles viruses expressing heterologous antigens of mumps and simian immunodeficiency viruses. Vaccine. 19(17-19). 2329–2336. 45 indexed citations

13.

Schwendener, Reto A., Bernhard Odermatt, Armando Zúñiga, et al.. (2001). Roles of Macrophages in Measles Virus Infection of Genetically Modified Mice. Journal of Virology. 75(7). 3343–3351. 63 indexed citations

14.

Grob, Philipp, et al.. (1999). Immortalized cell lines derived from mice lacking both type I and type II IFN receptors unify some functions of immature and mature dendritic cells. Immunology and Cell Biology. 77(2). 153–163. 8 indexed citations

15.

Zúñiga, Armando, et al.. (1997). Reduced intestinal colonisation with F18-positive enterotoxigenicEscherichia coliin weaned pigs fed chicken egg antibody against the fimbriae. FEMS Immunology & Medical Microbiology. 18(3). 153–161. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact